Novavax, Inc. (NVAX)
8.25
+0.38
(+4.83%)
USD |
NASDAQ |
Feb 06, 16:00
8.24
-0.01
(-0.12%)
After-Hours: 20:00
Novavax SG&A Expense (TTM) : 201.70M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.73B |
| Pfizer Inc. | 13.79B |
| Moderna, Inc. | 1.061B |
| Plus Therapeutics, Inc. | 11.09M |
| INVO Fertility, Inc. | 10.35M |